1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends

Botanical and Plant-Derived Drugs: Global Markets

  • August 2015
  • 172 pages
  • BCC Research
Report ID: 118047

Summary

Table of Contents

This BCC Research report analyzes the key growth areas in plant derived drugs, develops quantitative market projections and discusses compliance with the requirements for the botanical category of drugs, created in 2004, with its own U.S. Food and Drug Administration (FDA) regulations, guidelines and review process through 2020.

REPORT HIGHLIGHTS

The global market for botanical and plant-derived drugs was valued at $23.2 billion in 2013 and $24.4 billion in 2014. This total market is expected to reach $25.6 billion in 2015 and nearly $35.4 billion in 2020, with a compound annual growth rate (CAGR) of 6.6% from 2015 to 2020.

This report provides:

- An overview of the botanical drug industry, with the overall plant-derived drug industry as a backdrop and the global market for these drugs going forward.
- Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of CAGRs through 2020.
- A focus on legal, prescription-required therapeutic medicines sold in the open market; the study does not specifically cover herbals generally sold as dietary supplements (i.e., to promote overall “wellness” rather than to address a specific medical condition or symptoms).
- Examination of the industry structure, competition, and market drivers.
- Discussion of market size and segmentation, including breakdowns of sales by therapeutic area and geographic area.
- Observations and conclusions regarding the future of the botanical and plant-derived drug industry.

SCOPE OF REPORT

This report is an analytical business tool whose primary purpose is to describe the botanical drug industry with the overall plant-derived drug industry as a backdrop and the global market for these drugs going forward.

For the purposes of this report, botanicals are those drugs that are FDA-approved under the botanical drug pathway, while plant-derived drugs are both botanicals as well as other approved drugs that contain a mixture of natural plant-derived and synthetic or semisynthetic substances.

The study’s main focus is on legal, prescription-required therapeutic medicines sold in the open market. The study does not specifically cover herbals generally sold as dietary supplements (i.e., to promote overall “wellness” rather than to address a specific medical condition or symptoms). While there is a substantial market for these products, the medical value of many of these substances has not been demonstrated conclusively.

The study also does not cover the following:

- Underground or illicit drugs.
- Home remedies.
- Tribal medicines.
- Drugs derived from Archaea, bacteria and fungi (molds and yeasts).
- Nonmedicinal plant substances such as laxative cellulose and pectin fiber.
- Intravenously delivered nutrients of plant origin, such as dextrose.
- Plant-derived substances serving as pharmaceutical excipients, such as starch, methylcellulose, guar gum, vegetable oils, fatty acids, cocoa butter and candelilla wax.
- Plant substances serving in cosmetics, toiletries and personal care products.
- Microbial fermentation products, even those made with culture media incorporating corn steep liquor, starch or other plant-derived nutrients.
- Marine life.
The format of the study is organized around the following topics:
- Major types and applications of botanical drugs with plant-derived drugs as their backdrop.
- Industry structure.
- Market size and segmentation, including the breakdown of sales by therapeutic area and geographic area.
- Market drivers.
- Market projections through 2020.
- Competition.
- Observations and conclusions regarding the future of the botanical and plant-derived drug industry.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Global Ginseng Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • June 2017
  • by Accuray Research LLP

The Global Ginseng Market is poised to grow at a CAGR of around 11.9% over the next decade to reach approximately $7.51 billion by 2025. Some of the prominent trends that the market is witnessing include ...

Global Spirulina Market Outlook: 2017-2022

  • $ 4175
  • Industry report
  • April 2017
  • by Meticulous Research

Spirulina is one of the natural algae in the environment with various advantages and has no side effects, which can be consumed by the human beings as well as animals. It is a type of blue-green algae, ...

Global Ginseng Market 2017-2021

  • $ 3500
  • Industry report
  • June 2017
  • by Infiniti Research Limited

About Ginseng Ginseng is a slow-growing perennial plant with fleshy roots. It belongs to the genus Panax of the family Araliaceae. It is found in North America and in Eastern Asia, typically in coole ...


Download Unlimited Documents from Trusted Public Sources

Dietary Supplement Industry in the US

  • July 2017
    10 pages
  • Dietary Supplem...  

  • United States  

View report >

The future of the OTC Industry

  • June 2017
    3 pages
  • OTC  

    Alternative Med...  

  • India  

    World  

View report >

Dietary Supplement Industry

  • May 2017
    11 pages
  • Dietary Supplem...  

View report >

Otc Industry In The Us

5 months ago

Related Market Segments :

Herbal Supplement

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.